MLS^® FOR POST-COVID REHABILITATION

BIOLOGICAL PRINCIPLES AND CLINICAL EVIDENCE

The publication by the Journal of Inflammation Research “Evaluation of Adjunctive Photobiomodulation (PBMT) for COVID-19 Pneumonia via Clinical Status and Pulmonary Severity Indices in a Preliminary Trial” points out – as part of a clinical trial – the validity of MLS^® Laser Therapy for treating pulmonary infection caused by COVID-19. The results highlighted that the patients who underwent the therapy showed a rapid recovery and an improvement in the pulmonary indexes, avoiding hospitalisation in intensive care units or mechanical ventilation, with no consequences 5 months from the treatment. The researchers who analysed the clinical aspects and the biological principles linked to its use include Doctor Scott Sigman, the first to employ MLS^®, and Doctor Monica Monici, head of ASAcampus.

Why using MLS^® Laser Therapy in COVID-19 recovery: biological bases

Dr. Monica Monici

Why using MLS^® Laser Therapy in COVID-19 recovery: clinical trial

Dr. Scott Sigman

MiS EFFECTIVE IN ANTI-INFLAMMATORY ACTIVITY

NEW RESEARCH PUBLISHED

A new research report by ASAcampus: “Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing” which evaluated the anti-inflammatory activity of MiS from a cellular and molecular point of view. The results? The therapy has an important anti-inflammatory effect and is also effective in controlling fibroblast activity, probably responsible for a deleterious effect on the inflammation’s evolution.

READ THE RESEARCH REPORT

SWIMMER’S SHOULDER

BACK IN THE WATER...WITH LASER THERAPY

Known in the industry as rotator cuff tendinitis, swimmer’s shoulder is caused by excessive training or by an overload of the anatomic structures involved in the athletic action. Laser Therapy is the solution for those wishing to get back to their freestyle or backstroke quickly.

READ THE ARTICLE

NEW BEGINNING

IN-PRESENCE INTERNATIONAL TRADE EVENTS ARE BACK

By taking part in two important events in Asia and the Middle East - China International Medical Equipment Fair in Shanghai and Arab Health in Dubai – ASA once again resumes on stage meetings, focusing on MLS^®, which was also the key player at the Estonian congress “Rehabilitation of patients with lung diseases” with the M8 device. Face-to-face events do not however exclude digital ones: online webinars and training courses for the Human & Vet sector will also continue during the second semester.

COMPANY & SUSTAINABILITY

EL.EN. AMONG THE SUSTAINABILITY LEADERS FOR 2021

A valuable recognition for El.En., included in the list of the 150 companies “2021 sustainability leaders” compiled by the German company Statista in collaboration with Il Sole 24 Ore. The group which ASA has been an integral part of since 2003 was held up as an example for the manufacturing industry thanks to the initiatives undertaken to implement business whist respecting the planet and the people. A commitment that ASA also embraces with its virtuous approach to sustainable governance.

READ THE NEWS

MLS® FOR POST-COVID REHABILITATION